Triumf Inc.
Vancouver, BC Doing business as Canada's National Laboratory For Particle And Nuclear Physics
- UEI
- KX7NHYXE5BF7
- CAGE
- L0S08
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada
- Website
- triumf.ca
- Founded
- 1968
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 16 hours of beam time | Johnson Space Center | $12,058 | |
| 36 hours laser team at triumf national laboratory. Beam time use at facility. | Goddard Space Center | $23,400 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Niowave, Inc. | Lansing, MI | 325412 Pharmaceutical Preparation Manufacturing |
| Radiabeam Systems, LLC | Santa Monica, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Scintilex, LLC | Alexandria, VA | — |
| Esrf | Grenoble, Auvergne-Rhône-Alpes | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Omega P R&D, Inc. | New Haven, CT | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Triumf Inc., doing business as Canada's National Laboratory for Particle and Nuclear Physics, is an international non-profit organization that provides particle accelerator services for physics research. As a subawardee on federal grants, Triumf has provided uranium-230 production, isolation, and radiolabeling services using its particle accelerator, supporting radiopharmaceutical research funded through NIH grants to Cornell University.
Specifically, Triumf has received four federal subawards from Cornell University to produce uranium-230 by irradiating target materials using the Triumf particle accelerator. The radioactive uranium was then isolated via radiochemical procedures. Triumf subsequently carried out radiolabeling studies by combining the uranium-230 with chelators developed in the Cornell labs. This work was intended to facilitate Cornell's radiopharmaceutical research under NIH grants related to targeted alpha therapy. Through providing particle accelerator services paired with radiochemistry expertise, Triumf enabled the prime grantee Cornell University to advance its federally-funded nuclear medicine program in this collaborative grant arrangement.
Quick answers
Is Triumf Inc. registered in SAM.gov?
Yes. Triumf Inc.'s SAM.gov registration is active through January 26, 2027.
What is Triumf Inc.'s most recent federal award?
Triumf Inc.'s most recent federal contract award is 16 hours of beam time (NNJ16HD59P), from Johnson Space Center, on June 14, 2016.
On GovTribe
See Triumf Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors